XO Cross Catheter Platform successfully used in peripheral vascular procedures utilizing pedal artery retrograde access to treat complex Critical Limb Ischemia (CLI) patients. PARK CITY, Utah, Aug. 1, 2022 /PRNewswire/ — Transit Scientific reports multiple successful peripheral vascular…
Related Articles

News
Nature’s Sunshine CEO Terrence Moorehead Receives 2022 CEO Today USA Award
November 21, 2022
ucbiotech
News
Comments Off on Nature’s Sunshine CEO Terrence Moorehead Receives 2022 CEO Today USA Award
Terrence Moorehead recognized for leadership and ongoing global transformation LEHI, Utah, Nov. 21, 2022 /PRNewswire/ — Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company, announced today Nature’s Sunshine […]

News
#BIO22: Coming together at a critical time, Endpoints News looks at the key metrics on biopharma in a turbulent time
June 9, 2022
ucbiotech
News
Comments Off on #BIO22: Coming together at a critical time, Endpoints News looks at the key metrics on biopharma in a turbulent time
Bioregnum Opinion Column by John Carroll Back at the beginning of the year during JP Morgan, I came up with my usual set of projections for the year ahead and definitely got one thing wrong. […]

News
KAZIA’S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN PRECLINICAL MODELS OF MELANOMA
October 27, 2022
ucbiotech
News
Comments Off on KAZIA’S PAXALISIB DEMONSTRATES POSITIVE MONOTHERAPY EFFICACY SIGNALS IN PRECLINICAL MODELS OF MELANOMA
SYDNEY, Oct. 27, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of new data from an ongoing research collaboration with the Huntsman […]